These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11267185)

  • 21. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.
    Maksymowych WP; Jhangri GS; Aspeslet L; Abel MD; Trepanier DJ; Naicker S; Freitag DG; Cooper BL; Foster RT; Yatscoff RW
    J Rheumatol; 2002 Aug; 29(8):1646-52. PubMed ID: 12180723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricle.
    duBell WH; Gaa ST; Lederer WJ; Rogers TB
    Am J Physiol; 1998 Dec; 275(6):H2041-52. PubMed ID: 9843803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicological and pharmacokinetic effects following coadministration of brequinar sodium and cyclosporine to Sprague-Dawley rats.
    Barnes TB; Campbell P; Zajac I; Gayda D
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):71-4. PubMed ID: 8516950
    [No Abstract]   [Full Text] [Related]  

  • 24. ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.
    van Gelder T; Klupp J; Sawamoto T; Christians U; Morris RE
    Transplant Proc; 2001 May; 33(3):2420-1. PubMed ID: 11377580
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension.
    Zhang W; Victor RG
    Am J Hypertens; 2000 Sep; 13(9):999-1004. PubMed ID: 10981550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of calcineurin antagonists.
    Kapturczak MH; Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat.
    Moia LJ; Matsui H; de Barros GA; Tomizawa K; Miyamoto K; Kuwata Y; Tokuda M; Itano T; Hatase O
    Brain Res; 1994 Jun; 648(2):337-41. PubMed ID: 7522929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture.
    Norris CM; Blalock EM; Chen KC; Porter NM; Landfield PW
    Neuroscience; 2002; 110(2):213-25. PubMed ID: 11958864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ciclosporin therapy on xylazine/ketamine anaesthesia in a rat model.
    Loeffelbein DJ; Nieberler M; Steinstraesser L; Boeckmann R; Hoelzle F; Wolff KD; Kesting MR
    J Vet Pharmacol Ther; 2010 Feb; 33(1):100-2. PubMed ID: 20444032
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.
    Chiasson VL; Pakanati AR; Hernandez M; Young KJ; Bounds KR; Mitchell BM
    Hypertension; 2017 Jul; 70(1):183-191. PubMed ID: 28584011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computerized quantitation of immunosuppressive synergy for clinical protocol design.
    Chou TC; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3043-5. PubMed ID: 7940955
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
    Chakkera HA; Kudva Y; Kaplan B
    Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
    Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical safety evaluation of inhaled cyclosporine in propylene glycol.
    Wang T; Noonberg S; Steigerwalt R; Lynch M; Kovelesky RA; Rodríguez CA; Sprugel K; Turner N
    J Aerosol Med; 2007; 20(4):417-28. PubMed ID: 18158714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus and cyclosporine A are of no benefit to young rats with kaolin-induced hydrocephalus.
    Khan OH; Enno T; Del Bigio MR
    Pediatr Neurosurg; 2003 Dec; 39(6):309-13. PubMed ID: 14734865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury.
    Waller JR; Metcalfe MS; Nicholson ML
    Transplant Proc; 2002 Aug; 34(5):1481-3. PubMed ID: 12176449
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients.
    Büchler M; Leibenguth P; Le Guellec C; Carayon A; Watier H; Odoul F; Autret-Leca E; Lebranchu Y; Paintaud G
    Eur J Clin Pharmacol; 2004 Dec; 60(10):703-8. PubMed ID: 15619133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.